General discussion, page-236

In other news Cannvalate just rego'd and got ethics approval for a trial of theirs.
https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379550&isReview=true

Public title

Experiences of patients receiving medicinal cannabis: effects of different doses and formulations on symptoms and side effects.

Scientific title

Dosage patterns and efficacy of medicinal cannabis treatments in patients receiving medicinal cannabis for any condition

It's a massive trial with sample size of 2000 patients and set to run over 5 years. Targets are anyone who has been prescribed Cannabis by Cannvalate.

Health condition(s) or problem(s) studied:

Mental illness

Pain

Sleep quality

Cancer

Epilepsy

Multiple sclerosis

Many different conditions studied, I see Sleep quality stands out and perhaps so does Pain (OSA/TBI)? Very interesting, what does this mean?
No doubt this will be supplementary and the findings from this trial will help in all of IHL/Cannvalates specific target area trials.

Now waiting for our OSA ethics approval, clock is ticking!